Zobrazeno 1 - 10
of 212
pro vyhledávání: '"F, Juraschek"'
Autor:
Kráľ, Ján1 (AUTHOR) jan.kral.2@tuke.sk, Dzuro, Tibor1 (AUTHOR) tibor.dzuro@tuke.sk, Debski, Hubert2 (AUTHOR) h.debski@pollub.pl
Publikováno v:
Materials (1996-1944). Sep2024, Vol. 17 Issue 17, p4400. 37p.
Autor:
Liu, Qiuping1,2,3 (AUTHOR), Han, Jingxian1,2 (AUTHOR), Zhang, Xuezhu1,2 (AUTHOR) zhangxuezhu1999@126.com
Publikováno v:
Skin Research & Technology. Aug2024, Vol. 30 Issue 8, p1-7. 7p.
Autor:
Albelo, Isabel1 (AUTHOR) ivalbelo@ncsu.edu, Raineri, Rachel1 (AUTHOR), Salmon, Sonja1 (AUTHOR) sisalmon@ncsu.edu
Publikováno v:
Sustainable Chemistry. Jun2024, Vol. 5 Issue 2, p98-115. 18p.
Autor:
Szechyńska-Hebda, Magdalena1 (AUTHOR) m.szechynska-hebda@botany.pl, Hebda, Marek2 (AUTHOR) marek.hebda@pk.edu.pl, Doğan-Sağlamtimur, Neslihan3 (AUTHOR) neslihandogansaglamtimur@gmail.com, Lin, Wei-Ting4 (AUTHOR) wtlin@niu.edu.tw
Publikováno v:
Materials (1996-1944). May2024, Vol. 17 Issue 10, p2194. 23p.
Autor:
Presciutti, Andrea1 (AUTHOR) andrea.presciutti@unimercatorum.it, Gebennini, Elisa1 (AUTHOR), Liberti, Federica1 (AUTHOR), Nanni, Francesca2 (AUTHOR), Bragaglia, Mario2 (AUTHOR)
Publikováno v:
Materials (1996-1944). Jan2024, Vol. 17 Issue 1, p78. 16p.
Autor:
Camarinha-Matos, Luis M.1 (AUTHOR) cam@uninova.pt, Rocha, Andre Dionisio1 (AUTHOR), Graça, Paula1,2 (AUTHOR)
Publikováno v:
Journal of Intelligent Manufacturing. Feb2024, Vol. 35 Issue 2, p499-519. 21p.
Publikováno v:
Engineering Reports; Aug2024, Vol. 6 Issue 8, p1-14, 14p
Autor:
Raoufi, Kamyar, Haapala, Karl R.
Publikováno v:
Sustainability (2071-1050); Jul2024, Vol. 16 Issue 14, p5856, 20p
Autor:
A T, Lachand, E, Garcia-Giralt, J, Auvert, F, Juraschek, P, Mennecier, T, Pallangie, T, Moustafa
Publikováno v:
European urology. 5(4)
30 patients with advanced prostatic carcinomas received sequential polychemotherapy with association of vincristine (or VM 26), cyclophosphamide and 5-fluorouracil. In addition, 13 of these 30 patients received a dose of adriamycin during the first d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7507b0a56da95fdbbec167dbbc8a4ed1
https://pubmed.ncbi.nlm.nih.gov/436871
https://pubmed.ncbi.nlm.nih.gov/436871
Autor:
J P, Bergerat, P, Dufour, Y, Soyer, C, Bollack, D, Jacqmin, G, Prevot, F, Juraschek, G, Bailly, S, de Garis, J M, Lang
Publikováno v:
Presse medicale (Paris, France : 1983). 16(39)
The results of treatment of metastatic renal cell carcinoma have so far been very poor. Many phase II studies have shown that interferon alpha therapy is active in a significant proportion of patients (approximately 10 to 15% complete and partial rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::973878bae810cf3b0f8eba8d6ade6889
https://pubmed.ncbi.nlm.nih.gov/2962158
https://pubmed.ncbi.nlm.nih.gov/2962158